Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – For patients with acute MI given early unfractionated heparin, a switch to bivalirudin before undergoing primary percutaneous coronary intervention results in improved cardiac…
NEW YORK (Reuters Health) – After chemotherapy-induced remission of follicular lymphoma, vaccination with a patient-specific tumor-derived antigen improves disease-free survival, a multicenter team has shown. Furthermore, the vaccine…
NEW YORK (Reuters Health) – The excess risk of unexplained sudden death in psychiatric patients may be related to diabetes and dyslipidemia rather than to the antipsychotic drugs…
NEW YORK (Reuters Health) – The longitudinal decline in lung function seen in patients with common variable immunodeficiency and X-linked agammaglobulinemia is related to immunoglobulin replacement level and…
NEW YORK (Reuters Health) – Growth hormone treatment of adults isn’t associated with an increased risk of developing diabetes, according to a new report. “The strength of the…
NEW YORK (Reuters Health) – After catheter ablation, patients with obstructive sleep apnea (OSA) are more likely to experience recurrence of atrial fibrillation (AF) than are their OSA-free…
NEW YORK (Reuters Health) – Diabetes incidence falls during rosiglitazone treatment but returns to baseline after rosiglitazone withdrawal, according to the preprint version of a study that is…
NEW YORK (Reuters Health) – Clinicians faced with a case of shoulder dystocia during childbirth should consider delivering the posterior shoulder after they’ve tried the two primary accepted…
NEW YORK (Reuters Health) – For the treatment of ovarian endometriomas, laser vaporization is associated with earlier recurrences and more recurrences compared with laparoscopic cystectomy, although the differences…
NEW YORK (Reuters Health) – Patients with type 2 diabetes without retinopathy can be safely screened for sight-threatening vision problems every 3 years instead of every 1 or…
